This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
So, it shouldn’t be a huge surprise that Virginia didn’t launch a medical marijuana program until 2015, nearly two decades after California. Not much happened between 1979 and 2015, aside from preventing the repeal of the wonky 1979 law. The 2015 Virginia law is an affirmative defense law.
In the 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), the Department of Financial & Professional Regulation (IDFPR) states in its data summary, “Looking ahead to Fiscal Year 2025, IDFPR has already begun its efforts to further expand access to cannabis both to consumers and medical patients.
Even though laws were put into place that legalized MMJ and made it possible for qualifying patients to access the medication, dispensaries and sales had not yet come into play. According to data from the Missouri Department of Health and Senior Services, there are 192 licensed dispensaries in the state.
Our main product is the Ehave Dashboard which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insight using Blockchain technology. Forward-Looking Statement Disclaimer. For Investors Relations, please contact: Gabe Rodriguez. Phone: (623) 261-9046. Email: ir@ehave.com.
“We have long admired how Raquel and her team operate and our shared values around data transparency, accuracy and integrity.”. PSI Labs and pH Solutions share core values and by practicing integrity in our reporting and testing methods, we’re able to give consumers access to safe, accurate medicine,” said Raquel Keledjian, Ph.D.
Regulation 2015/2283 , which is the latest food regulation adopted by the European Parliament and the European Union (“EU”), defines “novel food” as “food that was not used for human consumption to a significant degree within the Union before 15 May 1997, irrespective of the dates of accession of the Member States to the Union.”.
A study of data from across the country has found no evidence that the legalization of medical cannabis and the establishment of dispensaries encourages marijuana use by young people. Lower Cannabis Use Among 9th Graders.
Company selects NEO as senior stock exchange of choice to access wider investor base and enhanced liquidity. Fully operational since June 2015, NEO puts investors first and provides access to trading across all Canadian-listed securities on a level playing field.
Cancer Pain Relief With Cannabis: What the New Study Shows Utilizing data from the Quebec Cannabis Registry in Canada, researchers sought to examine the safety and effectiveness of cannabis in addressing cancer pain. years between May 2015 and October 2018. The study participants had an average age of 57, and 48% were male.
They have data and reports in play and we presume have fairly healthy numbers in terms of B to B clients. said New Frontier Data Founder and CEO Giadha Aguirre de Carcer. based New Frontier Data was founded in 2014 and has grown to over a 50-person team, with three offices in the United States and Europe. Washington, D.C.-based
Building the bridge between brands and the marketplace through testing and the importance of good data. A need for data at all of these levels and data specific to product type drives more advanced methodology in the laboratories, often resulting in a better understanding of the matrix and more accurate data.
We look forward to providing all the benefits of a Tier 1 exchange, including access to institutional investors, increased quality of trading, and our white glove service and support.”. Fully operational since June 2015, NEO puts investors first and provides access to trading across all Canadian-listed securities on a level playing field.
Furthering the mystery of the cannabis-induced munchies, adults with safe, reliable access to legal recreational-cannabis spend more money on cookies, ice cream, and chips than their counterparts, according to a new study. The retail-data analysis covered more than 2,000 counties over a period of a decade, from 2006 to 2016.
The Czech Republic legalized therapeutic cannabis for selected patients in 2015, and health insurance companies have been covering up to 90% of the cost of the treatment since 2020. According to official data cited by the Czech News Agency (CTK), the treatment helped improve the health condition and well-being of patients in 69% of cases.
Our main product is the Ehave Dashboard which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insight using Blockchain technology. Forward-Looking Statement Disclaimer. For Investors Relations, please contact: Gabe Rodriguez. Phone: (623) 261-9046. Email: ir@ehave.com.
Fully operational since June 2015, NEO puts investors first and provides access to trading across all Canadian-listed securities on a level playing field. Additional Information and Where to Find It.
This platform allows brands and retailers to conveniently access critical operational services, including distribution and data insights, sophisticated inventory management and e-commerce solutions. Founded in 2015, Blackbird has built the largest B2B2C logistics infrastructure in the State of Nevada.
Our main product is the Ehave Telemetry Portal, which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insights. Additional information on Ehave can be found on the Company’s website at: www.ehave.com. Forward-Looking Statement Disclaimer. Contact: Ehave Inc.
So, every time we run that data, we would always know all the retail companies that are cannabis-related. HDL’s access to data relating to sales in the cannabis industry that no competitor has drawn criticism from some involved in California’s cannabis industry. Cantonization – California – Cannabis.
After months of development, my partner and I built and successfully launched the beta for our cannabis data-analytics software, Jade Insights. It’s a software platform that helps cannabis businesses augment their process by providing insights for data-backed decision-making. ” JOHN KAGIA. ” OPHELIA CHONG. .”
The report concluded that THC levels in people ingesting large amounts of hemp products could exceed a safety threshold for THC in food set by the group in 2015 and potentially lead to effects on the central nervous system and an increased heart rate. Open Access. In 2015, EFSA established an acute reference dose (ARfD) of 1 ?
By getting a medical card, you will be able to access marijuana for medical purposes. Cannabis use, employment, and income: fixed-effects analysis of panel data. Cannabis use, employment, and income: fixed-effects analysis of panel data. 3] Feingold, D., Goor-Aryeh, I., Delayahu, Y., & Lev-Ran, S. 4] Naeem Z. Goor-Aryeh, I.,
University of Mississippi researchers John Gardner and Bright Osei analyzed data from various sources to compare trends in the foster care system, particularly to compare states where cannabis has been legalized and where it hasn’t. This study is from 2015, and more recent research does not support its conclusions.
The difference is that medical patients may have access to higher dosages, among other benefits depending on their state, and receive a higher level of service to match them with the best products for their symptoms. Research is ongoing, but the existing data and anecdotal reports show potential. Nausea and vomiting.
The new law lists minority-owned businesses as ‘social and economic equity applicants,’ a designation that allows Black and brown New Yorkers a chance at participating in the cannabis industry by having access to licenses. Her concerns are borne out by MWBE data. However, Sen. Source: [link].
The survey is based on data from “1506 family practice doctors, internists, nurse practitioners, and oncologists who responded to the 2018 DocStyles, a web-based panel survey of clinicians.”. Clinicians Believe Cannabis Is Beneficial…So Politicians Should Not Prevent Access.
Similarly, local bans on legal sales over extended geographic areas can drive consumers without access to legal products within a reasonable distance of their homes to purchase substitute goods on the illicit market. impact-of-california-cannabis-taxes-on-legal-market.
million worth of cannabis to medical patients in Germany gives Tilray access to a country with a population and gross domestic product that are twice the size of its home country, Canada. According to Kennedy, Tilray’s exploration outside Canada started in 2015 – three years before legalization was implemented.
“This supports our position that cannabis should remain an illicit drug… We will continue to allow safe and controlled access to evidence-based medical treatment options.” ” At a Central Narcotics Bureau’s workplan seminar on May 24, Law and Home Affairs Minister K.
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Refractory paediatric epilepsy.
According to data from another American state, Colorado, cannabis edibles account for as much as 45% of all cannabis sales – which excludes those home-made edibles made from bought or grown cannabis bud (the flower we consume). The caregiver must be over 18 years old and patients may only have one caregiver. .
We compare biennial high school student self-reported survey data from Montevideo and regions in the interior of Uruguay post-legalization (2014–2018) and post initial implementation (2015–2018) to a synthetic counterfactual constructed using a weighted combination of 15 control regions in Chile.”
Veriheal does not support illegally consuming therapeutic substances such as psilocybin, but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies. The Fred W.
Mr Evans was a key figure in introducing Cann Global to the cannabis industry in 2015 after brokering the initial investment and acquisition of Medical Cannabis (MCL). For Cann Global, it means immediate access to distribution channels in Asia and further afield.
million) | Tax rate: 37% at retail since July 2015; 6.5% Until July 2015, taxes were quite high — 25% at three points of transfer — making it hard to compete with illegal sales. In addition to changing the tax rate to 37% in 2015, the legislature created a medical endorsement program to which adult-use stores could apply to join.
Company selects NEO to access wider investor base and enhanced liquidity. Fully operational since June 2015, NEO puts investors first and provides access to trading across all Canadian-listed securities on a level playing field. Trees is now available for trading on NEO under the symbol TREE.
So much so, in fact that, according to an August 28 article in CBC News , Alberta and Ontario are the only provinces which offer any solid data on cannabis poisonings and hospitalizations. But when sold legally in dispensaries, new users will have access to staff who understand how edibles work and will therefore be able to provide guidance.
Department of Cannabis Control (Accela Citizen Access). ” Per the California Agricultural Production and Irrigated Water Use report published by the Congressional Research Service in 2015, California irrigates over 830,000 acres of pasture. Los Angeles Open Data. Relevant Sources: Cooley, H. Retrieved from [link].
In 2018, medical cannabis became legal in the UK after a nationwide outpouring of support for two young boys who rely on cannabis oil to treat their severe and rare forms of epilepsy, but lingering concerns around the safety and efficiency of the medicine mean that access is still heavily restricted. THC – between 2015 and 2017.
States continue to expand their legal cannabis markets, with Maine formally adopting rules for adult-use cannabis sales, New Hampshire passing a law allowing physicians assistants to prescribe medical cannabis, and New Jersey soon to sign legislation expanding access to medical cannabis.
Up until December of 2015, regulatory limitations put in place by the FDA prohibited researchers from conducting CBD-related trials in the US. However, as reported by New Frontier Data reports, there are two selling points that are overwhelmingly driving growth: reducing anxiety and reducing inflammation. Why so little research?
The journal Science retracted George Ricaurte’s paper on the neurotoxic effects of MDMA in primates after MAPS sent multiple letters to the journal and an investigation revealed that the data were invalid due to a drug labeling error. MAPS published results from the first study of LSD therapy in over 40 years. Reddit awarded $82,765.95
New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. Ability to provide appropriate research data. since 2015. Criterion 5. Criterion 7.
Since 2015, the FDA has sent warning letters to companies allegedly illegally selling unapproved cannabinoid (CBD) products. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”. The FDA warning letters caution sellers about claims they make to market their products. Taking CBD can relieve pain.”. “In
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content